Compare Blackrock Inc (BLK) vs Merck & Co., Inc. (MRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Blackrock Inc vs Merck & Co., Inc. — how do they compare? Blackrock Inc trades at $1,095.5 (market cap $158.94B), while Merck & Co., Inc. trades at $123.93 (market cap $298.31B). The key difference: Merck & Co., Inc. is the larger of the two by market cap, and Merck & Co., Inc. pays the higher dividend (2.82%). Which is the better fit depends on your goals.
| BLK | MRK | |
|---|---|---|
Market Cap | $158.94B | $298.31B |
Volume | 641,547 | — |
Sector | Financials | Health |
52-Week High | $1.20K | $129.52 |
52-Week Low | $922.90 | $77.60 |
Enterprise Value | $160.76B | $341.72B |
Dividend Yield | 2.24% | 2.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Merck (MRK) trades at $120.80, down 2.6% in the last session. The stock shows strong fundamentals with 2025 revenue of $65.01 billion and net income of $18.25 billion, yielding a net margin of 28.07%. Recent earnings beats and a bullish technical signal, with support at $120, highlight resilience. The acquisition of Terns Pharmaceuticals, announced April 7, 2026, aims to bolster its oncology pipeline, reflecting strategic growth initiatives amid a competitive landscape.
The outlook for MRK is positive, supported by robust profitability, strategic acquisitions, and a consensus price target of $137.30. Risks include rising debt levels, with debt-to-asset ratio increasing to 36.06% in 2025, and potential margin pressure from R&D investments. Institutional buying activity and a 67.57% buy rating from analysts underscore confidence, but investors should monitor execution risks and macroeconomic factors affecting the pharmaceutical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Blackrock Inc
BlackRock, Inc. provides investment management services to institutional clients and to retail investors through various investment vehicles. The Company manages funds, as well as offers risk management services. BlackRock serves governments, companies, and foundations worldwide.
Read more on BLK →About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →
